17-Nov-2026 14:02:36

CAPLIPOINTGeneral news

CAPLIN POINT : US FDA CLASSIFIES SUBSIDIARY FACILITY AS OAI

• US FDA determined inspection classification of Caplin Steriles Limited (subsidiary) facility as Official Action Indicated (OAI) • Facility at Gummidipoondi makes injectables and ophthalmics; inspected August 13 to August 21, 2026 • Inspection had concluded with 10 observations that were procedural in nature • Company received the communication on November 16, 2026 • Company does not expect any material impact on financials or operations; facility continues to manufacture and supply products • Company to work with US FDA on corrective and preventive actions

Caplin Point Laboratories Ltd

Open attachment

← Back to feed